Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors

Prostaglandins (PGs) with best-defined renal functions are PGE2 and prostacyclin (PGI2). These vasodilatory PGs increase renal blood flow and glomerular filtration rate under conditions associated with decreased actual or effective circulating volume, resulting in greater tubular flow and secretion...

Full description

Bibliographic Details
Main Author:	Kim, Gheun-Ho
Format:	Online
Language:	English
Published:	The Korean Society of Electrolyte and Blood Pressure Research 2008
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894486/

Similar Items

Cyclooxygenase and Prostaglandin in Cancer
by: Kim, Jong-Woo
Published: (2012)

Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells
by: Kirtikara, Kanyawim, et al.
Published: (1998)

Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
by: Nørregaard, Rikke, et al.
Published: (2015)

Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer
by: Bronger, Holger, et al.
Published: (2012)

Prostaglandin levels in seminal plasma and sperm extracts of the domestic turkey, and the effects of cyclooxygenase inhibitors on sperm mobility
by: Kennedy, Jessica H, et al.
Published: (2003)

Prostaglandins, Masculinization and Its Disorders: Effects of Fetal Exposure of the Rat to the Cyclooxygenase Inhibitor- Indomethacin
by: Dean, Afshan, et al.
Published: (2013)

Cyclooxygenase-2 inhibitors: promise or peril?
by: Mengle-Gaw, Laurel J, et al.
Published: (2002)

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
by: Howe, Louise R
Published: (2007)

Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain
by: Wu, Tao, et al.
Published: (2011)

Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders
by: Yui, Kunio, et al.
Published: (2015)

Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection
by: Guerrero, Néstor A., et al.
Published: (2015)

Correction: Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection
by: Guerrero, Néstor A., et al.
Published: (2015)

Production of Prostaglandin E2 and I2 Is Coupled with Cyclooxygenase-2 in Human Follicular Dendritic Cells
by: Cho, Whajung, et al.
Published: (2011)

Cannabinoid system and cyclooxygenases inhibitors
by: Păunescu, H, et al.
Published: (2011)

Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ – prostaglandin E2 dependent proliferation of growth plate chondrocytes
by: Brochhausen, Christoph, et al.
Published: (2006)

Up-regulation of cyclooxygenase-2-derived prostaglandin E2 in colon cancer cells resistant to 5-fluorouracil
by: Choi, Cheol Hee, et al.
Published: (2011)

Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
by: Tabrizchi, Reza
Published: (2006)

Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
by: Xu Kang, et al.
Published: (2017-08-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Smith, Francine G., et al.
Published: (2012)

Cyclooxygenase 2 and Prostaglandin E2 are not Involved in N-Nitrosodiethylamine-Initiated Early Rat Hepatocarcinogenesis
by: Said, Mahmoud M., et al.
Published: (2009)

The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
by: Akarasereenont, P, et al.
Published: (1999)

Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2
by: Gabasa, Marta, et al.
Published: (2013)

Tolerance of neurite outgrowth to Rho kinase inhibitors decreased by cyclooxygenase-2 inhibitor☆
by: Duan, Weigang, et al.
Published: (2012)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
by: Li, Kang-Hua, et al.
Published: (2013)

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
by: Pourbakht, Akram
Published: (2013)

Upregulation of Prostaglandin Receptor EP1 Expression Involves Its Association with Cyclooxygenase-2
by: Sood, Rapita, et al.
Published: (2014)

Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
by: Yang, Hao-Jie, et al.
Published: (2016)

Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia
by: Hayashi, Genki, et al.
Published: (2014)

Positive correlation between patency and mRNA levels for cyclooxygenase-2 and prostaglandin E synthase in the uterine cervix of bitches with pyometra
by: TAMADA, Hiromichi, et al.
Published: (2015)

Electrolyte and Acid-Base Disturbances Induced by Clacineurin Inhibitors
by: Lee, Chang Hwa, et al.
Published: (2007)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris, Randall E, et al.
Published: (2012)

Effects of Lipoic Acid Supplementation on Activities of Cyclooxygenases and Levels of Prostaglandins E2 and F2 α Metabolites, in the Offspring of Rats with Streptozotocin-Induced Diabetes
by: Al-Matubsi, Hisham Y., et al.
Published: (2016)

Sustained Release of Prostaglandin E2 in Fibroblasts Expressing Ectopically Cyclooxygenase 2 Impairs P2Y-Dependent Ca2+-Mobilization
by: Pimentel-Santillana, María, et al.
Published: (2014)

Dysregulation of Renal Cyclooxygenase-2 in Rats with Lithium-induced Nephrogenic Diabetes Insipidus
by: Kwon, Tae-Hwan
Published: (2007)

The cyclooxygenases
by: Chandrasekharan, NV, et al.
Published: (2004)

Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case–control studies
by: Vinogradova, Y, et al.
Published: (2011)

Importance of adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment
by: Gargallo, Carla J., et al.
Published: (2013)

Inhibitors of cyclooxygenase-2-dependent modulation of functional characteristics of leukocytes
by: A V Pasechnik, et al.
Published: (2009-03-01)

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
by: Seliger, Corinna, et al.
Published: (2016)

Study of Osteoarthritis Treatment with Anti-Inflammatory Drugs: Cyclooxygenase-2 Inhibitor and Steroids
by: Cho, Hongsik, et al.
Published: (2015)